Baxter International Inc (BAX)

Industry Medical Instruments & Supplies


This stock can be held in an Investment ISA and an Investment Account
Sell

$18.60

Buy

$19.38

arrow-up$0.25 (+1.32%)

Prices updated at 13 Dec 2025, 00:41 EST
| Prices minimum 15 mins delay
|
Prices in USD

Baxter International Inc operates in the healthcare industry. It provides renal and hospital products such as infusion systems and systems, parenteral nutrition therapies, and biosurgery products.

Income statement

20232024
10,360m10,636m
4,150m3,984m
707m439m
6.824.13
2,656m-649m
1,734m1,116m
Sales, General and administrative2,953m2,967m
Interest expenses508m408m
Provision for income taxes61m37m
Operating expenses3,443m3,545m
Income before taxes242m-289m
Net income available to common shareholders2,656m-649m
5.25-1.27
Net interest income-439m-341m
Advertising and promotion--
Net investment income, net--
Realised capital gains (losses), net--
Total benefits, claims and expenses--
Earnings per share (diluted)5.25-1.27
Free cash flow per share1.760.767
Book value/share15.958415.4073
Debt equity ratio1.3513451.524555

Balance sheet

20232024
Current assets9,600m8,853m
Current liabilities6,503m6,511m
Total capital19,532m17,338m
Total debt14,364m13,449m
Total equity8,402m6,964m
Total non current liabilities--
Loans11,130m10,374m
Total assets28,276m25,782m
Total liabilities--
Cash and cash equivalents3,194m1,764m
Common stock508m511m

Cash flow

20232024
Cash at beginning of period1,722m3,198m
Cash dividends paid-586m-590m
1,034m559m
Investments (gains) losses3,213m-626m
3,198m2,414m
Net income--
1,726m1,019m
-692m-460m
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.